
With inflation, energy markets and interest rate expectations all moving at once, many investors are looking at smaller stocks that aim to keep financial risk in check. The Financially Fit Penny Stocks screener focuses on companies trading below 5 that still show signs of solid balance sheet strength. That filter can help you concentrate on potential opportunities where financial health is a priority, even at lower share prices. This article highlights three stocks from that screener and explains why each one stands out in the current mix of global inflation, policy uncertainty and uneven economic data.
Overview: DroneShield is a Sydney based defence technology company that builds hardware and software to detect and neutralise hostile drones, selling its counter drone platforms to military, security and critical infrastructure customers across multiple regions.
Operations: DroneShield currently generates all reported revenue of about A$216.8 million from its Aerospace and Defense segment, primarily across Australia, the wider Rest of World and the USA.
Market Cap: A$1.9b
DroneShield sits at the intersection of rising defence spending and a permanent need to manage drone threats. This is turning counter UAS capabilities into a regular line item in defence and security budgets rather than a one off purchase. The company has become profitable, and analysts expect strong earnings and revenue growth, helped by movement toward repeat institutional procurement across NATO and US defence channels, plus high profile deployments such as its role in the FIFA World Cup 2026 security system. Investors should still pay close attention to funding risk from reliance on external borrowing, relatively low current ROE and the ongoing ASIC investigation, as these could add volatility around what is otherwise a fast growing, contract driven story.
DroneShield’s contract momentum and defence exposure are already in focus, but the missing piece for many investors is how analysts frame the next leg of this story. Get the full context in the analyst forecasts for DroneShield
Overview: Sigma Healthcare is a pharmacy wholesaler and franchisor in Australia that supplies medicines and health products to community pharmacies, supports franchise brands like Chemist Warehouse, Amcal and Discount Drug Stores, and also provides logistics and health services, including online channels.
Operations: Sigma Healthcare generates about A$9.5b in revenue from its Healthcare activities, with around A$9.2b from Australia and A$389.8m from international markets.
Market Cap: A$32.9b
Sigma Healthcare gives you exposure to the Australian pharmacy network. Forecast earnings growth is 15% a year and revenue is also expected to grow faster than the broader market. At the same time, the stock trades on a high P/E multiple and profit margins have moved from 11.5% to 6.3%, so you are paying up for that growth story while returns on equity remain modest. The business is also fully funded by external borrowing and board independence looks limited, which adds another layer of risk. For investors who want a higher growth healthcare stock but are willing to accept governance and funding questions, Sigma stands out from many other penny stocks in this screener.
Sigma Healthcare’s growth story is racing ahead while funding and governance questions sit in the background. Before you decide how that trade off stacks up, scan the 3 key rewards and 1 important warning sign.
Overview: Stanmore Resources is a Brisbane based coal producer that explores, develops and operates metallurgical coal assets across Queensland, supplying steelmakers with coal used in blast furnace production, and holds a large tenement position across the Bowen and Surat basins.
Operations: Stanmore Resources currently generates about US$1.9b in revenue from producing and selling metallurgical and thermal coal, with customers across Asia, Europe and South America.
Market Cap: A$2.5b
Stanmore Resources sits in a corner of the coal market that is closely tied to steel demand. This gives you exposure to potential volume and pricing upside if long term Indian and Asian steel consumption stays firm, while its cost focused mine improvements aim to rebuild margins after recent losses. Some analysts expect earnings to recover from a current loss to a higher level over the next few years, yet the stock trades on a low P/S multiple and a discount to certain value estimates, which can appeal to investors hunting for mispriced turnarounds. However, revenue is expected to edge lower, earnings remain sensitive to coal prices and weather at a small set of Queensland mines, and the dividend is not yet well covered by earnings.
Stanmore Resources appears to be a coal turnaround story hiding in plain sight, with cost-focused mine improvements and a low P/S multiple that may indicate mispriced potential. See how analysts frame the path ahead in the analyst forecasts for Stanmore Resources
The three stocks in this article are only a small sample, and the full screener has identified 403 more companies with equally compelling financial stories inside the Financially Fit Penny Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter to you so you can focus on the highest conviction opportunities in this corner of the market.
If Stanmore Resources or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
New ideas move fast. Some stocks are building quiet momentum while others are dropping off radars. Spot fresh breakouts that are under the radar for now and consider them early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com